Certified Procurement Transplant Coordinator (CPTC) Practice Exam

The choice to discontinue vancomycin in a potential renal donor is supported by its nephrotoxic properties. Vancomycin is an antibiotic used to treat a variety of bacterial infections, particularly those caused by gram-positive bacteria. However, it is known to cause damage to the kidneys, especially when used at high doses or for prolonged periods. Since renal donors must be assessed for optimal kidney function to ensure their kidneys are healthy enough for donation, any medication that poses a risk of further kidney impairment should be reconsidered.

In the context of potential renal donors, it is crucial to manage any renal stress and avoid drugs that can negatively impact kidney health. Gentamicin is also nephrotoxic and would similarly need careful consideration in a donor candidate; however, it is not the chosen answer because vancomycin is often in more critical consideration due to its usage in specific situations that are frequent in hospital settings. Amoxicillin and clindamycin are generally considered safer options with a much lower risk of causing nephrotoxicity, making them less of a concern in the management of potential renal donors. Thus, the decision to discontinue vancomycin aligns with best practices to ensure the preservation of renal function before the donation process.